ARCHIVES

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

May 11, 2007

NCI Advisors Approve Plans To Continue Current Research Programs.

July 3, 2008

Final Issue of ‘76

December 10, 1976

Retrovirus Vaccination Is Feasible, Workshop Participants Conclude

May 3, 1985

Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.

January 25, 2002

Diagnosis-Treatment Cidac contract Gets Recompetition Okay

December 16, 1983